Urine bombesin-like peptide elevation precedes clinical evidence of bronchopulmonary dysplasia.
暂无分享,去创建一个
[1] B. Yoder,et al. Neonatal chronic lung disease in extremely immature baboons. , 1999, American journal of respiratory and critical care medicine.
[2] A. Jobe,et al. Mechanisms initiating lung injury in the preterm. , 1998, Early human development.
[3] Y. Miller,et al. Urinary bombesin‐like peptide levels in infants and children with bronchopulmonary dysplasia and cystic fibrosis , 1998, Pediatric pulmonology.
[4] M. Palta,et al. Associations between family history of asthma, bronchopulmonary dysplasia, and childhood asthma in very low birth weight children. , 1998, American journal of epidemiology.
[5] B. Yoder,et al. Bombesin-like peptide mediates lung injury in a baboon model of bronchopulmonary dysplasia. , 1998, The Journal of clinical investigation.
[6] R. Parker,et al. Evidence from twin study implies possible genetic susceptibility to bronchopulmonary dysplasia. , 1996, Seminars in perinatology.
[7] D. Richardson,et al. LATE PULMONARY OUTCOMES POORLY PREDICTED BY EARLY RISK FACTORS IN VERY LOW BIRTH WEIGHT INFANTS • 1566 , 1996, Pediatric Research.
[8] J. Torday,et al. Bombesin and [Leu8]phyllolitorin promote fetal mouse lung branching morphogenesis via a receptor-mediated mechanism. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[9] C. Willett,et al. Modulation of oncogene and tumor suppressor gene expression in a hamster model of chronic lung injury with varying degrees of pulmonary neuroendocrine cell hyperplasia. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[10] A. Jobe,et al. Beneficial effects of the combined use of prenatal corticosteroids and postnatal surfactant on preterm infants. , 1993, American journal of obstetrics and gynecology.
[11] R. Parker,et al. Improved survival accounts for most, but not all, of the increase in bronchopulmonary dysplasia. , 1992, Pediatrics.
[12] W. Northway. Bronchopulmonary dysplasia: twenty-five years later. , 1992, Pediatrics.
[13] Y. Miller,et al. Urinary levels of bombesin-like peptides in asymptomatic cigarette smokers: a potential risk marker for smoking-related diseases. , 1992, Cancer research.
[14] J. Gaer,et al. CGRP-immunoreactive endocrine cell proliferation in normal and hypoxic rat lung studied by immunocytochemical detection of incorporation of 5′-bromodeoxyuridine , 1992, Cell and Tissue Research.
[15] M. De la Fuente,et al. Modulation of phagocytic function in murine peritoneal macrophages by bombesin, gastrin-releasing peptide and neuromedin C. , 1991, Immunology.
[16] S. Hurd,et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. , 1987, Pediatrics.
[17] J. Cunningham,et al. Stability of bombesin in serum, plasma, urine, and culture media. , 1985, Clinical chemistry.
[18] M. Escobedo,et al. A baboon model of bronchopulmonary dysplasia. II. Pathologic features. , 1982, Experimental and molecular pathology.
[19] K. Becker,et al. Increased serum and urinary calcitonin levels in patients with pulmonary disease. , 1981, Chest.
[20] L. Taussig,et al. Family history of asthma in infants with bronchopulmonary dysplasia. , 1980, Pediatrics.
[21] J. Lauweryns,et al. Intrapulmonary neuro-epithelial bodies in newborn rabbits , 1977, Cell and Tissue Research.
[22] Pearse Ag. The diffuse neuroendocrine system and the apud concept: related "endocrine" peptides in brain, intestine, pituitary, placenta, and anuran cutaneous glands. , 1977, Medical biology.
[23] M. Impicciatore,et al. The bronchoconstrictor action of the tetradecapeptide bombesin in the guinea‐pig , 1973, The Journal of pharmacy and pharmacology.
[24] W. Northway,et al. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. , 1967, The New England journal of medicine.
[25] S. White,et al. Migration of 3T3 and lung fibroblasts in response to calcitonin gene-related peptide and bombesin. , 1999, Experimental lung research.
[26] M. Sunday. Bioactive Peptides and Lung Development , 1999 .
[27] L. Bianchi,et al. Bombesin enhances monocyte and macrophage activities: possible role in the modulation of local pulmonary defenses in chronic bronchitis. , 1996, Respiration; international review of thoracic diseases.
[28] L. Kaplan,et al. Gastrin-releasing peptide (mammalian bombesin) gene expression in health and disease. , 1988, Laboratory investigation; a journal of technical methods and pathology.
[29] J. Lock,et al. Pulmonary Neuroendocrine Cells in Hyaline Membrane Disease and Bronchopulmonary Dysplasia , 1982, Pediatric Research.